×
IRadimed Pre-Tax Profit Margin 2013-2024 | IRMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
IRadimed pre-tax profit margin from 2013 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
View More
IRadimed Pre-Tax Profit Margin 2013-2024 | IRMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
IRadimed pre-tax profit margin from 2013 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.2B
Intuitive Surgical (ISRG)
$171.7B
Alcon (ALC)
$47.9B
IQVIA Holdings (IQV)
$43.7B
IDEXX Laboratories (IDXX)
$42.2B
Edwards Lifesciences (EW)
$40.5B
DexCom (DXCM)
$27.6B
STERIS (STE)
$23.8B
SONOVA HOLDING (SONVY)
$21.2B
Waters (WAT)
$19.5B
Hologic (HOLX)
$19B
Sysmex ADR (SSMXY)
$12.6B
Fresenius Medical Care AG KGaA (FMS)
$12.3B
Teleflex (TFX)
$11.4B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.7B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5.2B
Integer Holdings (ITGR)
$4.2B
PROCEPT BioRobotics (PRCT)
$4.1B
Tandem Diabetes Care (TNDM)
$2.8B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.6B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.5B
Nihon Kohden (NHNKY)
$2.5B
RxSight (RXST)
$2.1B
Integra LifeSciences Holdings (IART)
$1.3B
Pulse Biosciences (PLSE)
$1.2B